Johnson & Johnson
NYSE:JNJ

Watchlist Manager
Johnson & Johnson Logo
Johnson & Johnson
NYSE:JNJ
Watchlist
Price: 202.48 USD -1.39% Market Closed
Market Cap: 487.8B USD

P/E
Price to Earnings

19.4
Current
18.8
Median
21.8
Industry
Higher than median
Lower than industry value

The Price to Earnings (P/E) ratio shows how much investors are willing to pay for each dollar of a company’s earnings. It’s calculated by dividing the company’s market value by its net income.

P/E
19.4
=
Market Cap
487.2B USD
/
Net Income
25.1B USD
All Countries
Close
Market Cap P/E
US
Johnson & Johnson
NYSE:JNJ
487.2B USD 19.4
US
Eli Lilly and Co
NYSE:LLY
959.5B USD 52.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP -15 783.5
CH
Roche Holding AG
SIX:ROG
246.8B CHF 26.2
UK
AstraZeneca PLC
LSE:AZN
209.6B GBP 29.7
CH
Novartis AG
SIX:NOVN
205.1B CHF 17.7
US
Merck & Co Inc
NYSE:MRK
250.9B USD 13.2
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 13.1
IE
Endo International PLC
LSE:0Y5F
202.5B USD -69.3
US
Pfizer Inc
NYSE:PFE
146.1B USD 14.9
FR
Sanofi SA
PAR:SAN
102.9B EUR 7.5
Earnings Growth PEG
US
Johnson & Johnson
NYSE:JNJ
Average P/E: 21.5
19.4
29%
0.7
US
Eli Lilly and Co
NYSE:LLY
52.1
50%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
CH
Roche Holding AG
SIX:ROG
26.2
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
29.7
38%
0.8
CH
Novartis AG
SIX:NOVN
17.7
18%
1
US
Merck & Co Inc
NYSE:MRK
13.2
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.1
7%
1.9
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -69.3 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.9
31%
0.5
FR
Sanofi SA
PAR:SAN
7.5
26%
0.3

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
18.4
2-Years Forward
P/E
17.4
3-Years Forward
P/E
16.2